Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.92 | 10.11 |
| PEG Ratio (TTM) | 0.12 | -1.35 |
| P/S Ratio (TTM) | 0.30 | 0.41 |
| P/B Ratio (TTM) | 1.41 | 2.61 |
| P/FCF Ratio (TTM) | 42.77 | 3.94 |
| Price to 5YR AVG Earnings Ratio | 12.97 | 13.11 |
| Price to 5YR AVG FCF Ratio | 19.69 | 25.85 |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.34% | 6.86% |
| ROE (TTM) | 40.64% | 30.77% |
| Net Profit Margin (TTM) | 3.27% | 3.68% |
| ROIC 5YR AVG | 9.65% | 17.45% |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 112.60% | 105.01% | 56.34% |
| Revenue | 2.26% | 8.83% | 12.47% |
| Net Income | 129.76% | 109.77% | 59.33% |
| Cash Flow | 4,632.46% | 433.08% | 262.22% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.26 | 1.44 |
| Quick Ratio (TTM) | 0.72 | 0.96 |
| D/E Ratio (TTM) | 1.71 | 0.79 |
| Interest Coverage (TTM) | 5.22 | 8.56 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 2.35 | 3.38 |
| LTL to 5YR AVG FCF | 9.67 | 7.48 |
| Shares Outstanding Growth 5YR AVG | -0.05% | -0.80% |